2022-11-11T05:42:16-06:00 2021-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2021-01-01 912154267 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 York Avenue New York NY 10065 MARK K SVENNINGSON SVP FINANCE 6462273092 2022-11-10 true MARK K SVENNINGSON 999009999 JENNIFER D RHODERICK P00395735 3176817000 2 2021 2022-09-23 18:48:47Z SELWYN M VICKERS MD 1275 York Avenue New York NY 10065 8361062738 true true 3475 X www.mskcc.org X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION , AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 114 105 29732 262 23658668 8274194 477139895 817480000 4604648000 5422024000 197912000 534488000 104149879 156818000 5383849774 6930810000 24726000 21438500 0 0 3175468400 3314805014 0 0 71894554 2599184374 2808113486 5799378774 6144357000 -415529000 786453000 13315250000 14941252000 5246332000 5116410000 8068918000 9824842000 X THE MISSION OF MEMORIAL SLOAN-KETTERING CANCER CENTER IS TO LEAD IN THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF CANCER AND ASSOCIATED DISEASES THROUGH PROGRAMS OF EXCELLENCE IN RESEARCH, EDUCATION, OUTREACH AND COST-EFFECTIVE PATIENT CARE. LEADERSHIP IN PATIENT CARE: WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE, WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARCH EX false false 4974179000 21438500 5251278000 PATIENT CARE: MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. Throughout the COVID-19 pandemic, MSKCC has worked to protect and assist the public. In the Spring of 2020, Memorial Hospital accepted transfers of COVID-positive cancer patients from other New York hospitals to free up space at those hospitals and provide specialized care to such patients. Similarly, MSKCC has undertaken COVID-19 vaccination efforts not just for its patients and employees, but also for community health care partners and the public. Specifically, MSKCC opened pop up clinics at locations in Harlem and Brooklyn, as well as working with New York City to open a public vaccination site at the Abyssinian Baptist Church in Harlem, which administered approximately 12,000 doses over the course of almost four months. 821244000 170746000 RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, GENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING 1,159 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. 213880308 EDUCATION: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM HAS BEEN ENROLLING STUDENTS SINCE 2006 AND TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. 6009303308 true true false true false false false false false true true true false false true false false true true true true false false false false false true true true true true true false false false false false true false false true true true false false false true true true true false false true 1329 0 true 29732 true true true false false false false false false false false false true false X 114 105 true false false false true true false true true false false true true true true true true true true true true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X MARK K SVENNINGSON 6462273414 633 3RD AVENUE NEW YORK NY 10017 X CRAIG B THOMPSON MD PRESIDENT & CEO 50.0 0.0 X X 2684526 0 280957 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 50.0 0.0 X 2731258 0 87025 BABAK MEHRARA MD CHIEF ATTENDING-SURGERY 50.0 0.0 X 2570007 0 77246 JEFFREY DREBIN MD CHAIRMAN ATTENDING-SURGERY 50.0 0.0 X 2400718 0 79449 JOSEPH DISA MD ATTENDING PLASTIC SURGERY 50.0 0.0 X 2128227 0 82653 ROBERT KURTZ MD ATTENDING 50.0 0.0 X 2024064 0 49597 DAVID JONES MD CHIEF ATTENDING-SURGERY 50.0 0.0 X 2003247 0 50610 KATHRYN MARTIN EVP & COO 50.0 0.0 X X 1760489 0 85572 MICHAEL HARRINGTON EVP & CFO 50.0 0.0 X X 1774641 0 63339 SIMON POWELL MD DIRECTOR 50.0 0.0 X 1702366 0 67451 LISA DEANGELIS MD PHYSICAN IN CHIEF 50.0 0.0 X 1549430 0 75202 JOAN MASSAGUE PHD DIRECTOR 50.0 0.0 X 1468290 0 74498 JORGE LOPEZ ESQ EVP GENERAL COUNSEL 50.0 0.0 X 1307132 0 80359 KERRY BESSY SVP-CHIEF HR OFFICER 50.0 0.0 X 1260979 0 81357 KENNETH MANOTTI SVP DEVELOPMENT 50.0 0.0 X 1250637 0 67241 ROXANNE TAYLOR SVP CHIEF MARKT/COMM 50.0 0.0 X 1149672 0 38174 DEBRA BERNS ESQ SVP CHIEF RISK OFFICER 50.0 0.0 X X 987455 0 48303 ERIC M COTTINGTON PHD SVP RESEARCH AND TECHNOLOGY 50.0 0.0 X 950138 0 73969 FREDRICK GROVES EVP HOSPITAL ADMINISTRATION 50.0 0.0 X 940785 0 65476 MARK SVENNINGSON SVP FINANCE 50.0 0.0 X X 850147 0 73017 EDWARD MAHONEY SVP FACILITIES MANAGEMENT 50.0 0.0 X 837621 0 49785 CLAUS JENSEN EVP CHIEF DIGITAL OFFICER 50.0 0.0 X 688368 0 43434 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL 50.0 0.0 X 541368 0 58986 PATRICIA C SKARULIS FRMR SVP CHIEF INFORMATION 0.0 0.0 X 377770 0 0 AVICE MEEHAN FORMER SVP CH COMM OFFICER 0.0 0.0 X 198979 0 11714 RICHARD I BEATTIE SEE SCH O STARTS PG 175 6.0 0.0 X 0 0 0 IAN COOK SEE SCHEDULE O 3.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER SEE SCHEDULE O 3.0 0.0 X 0 0 0 ANTHONY B EVNIN SEE SCHEDULE O 3.0 0.0 X 0 0 0 ROGER W FERGUSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 HENRY A FERNANDEZ SEE SCHEDULE O 3.0 0.0 X 0 0 0 WILLIAM E FORD SEE SCHEDULE O 3.0 0.0 X 0 0 0 RICHARD N FOSTER SEE SCHEDULE O 3.0 0.0 X 0 0 0 STEPHEN FRIEDMAN SEE SCHEDULE O 3.0 0.0 X 0 0 0 ELLEN V FUTTER SEE SCHEDULE O 4.0 0.0 X 0 0 0 LOUIS V GERSTNER JR SEE SCHEDULE O 7.0 0.0 X X 0 0 0 JONATHAN N GRAYER SEE SCHEDULE O 3.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN JR SEE SCHEDULE O 3.0 0.0 X 0 0 0 WILLIAM HELMAN SEE SCHEDULE O 3.0 0.0 X 0 0 0 JEFFREY P JOHNSON SEE SCHEDULE O 2.0 0.0 X 0 0 0 MARGARET KEANE SEE SCHEDULE O 3.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS SEE SCHEDULE O 6.0 0.0 X X 0 0 0 JAMIE C NICHOLLS SEE SCHEDULE O 5.0 0.0 X X 0 0 0 JAMES G NIVEN SEE SCHEDULE O 5.0 0.0 X 0 0 0 BRUCE C RATNER SEE SCHEDULE O 3.0 0.0 X 0 0 0 CLIFTON S ROBBINS SEE SCHEDULE O 7.0 0.0 X X 0 0 0 ALEXANDER T ROBERTSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 JAMES D ROBINSON III SEE SCHEDULE O 3.0 0.0 X 0 0 0 VIRGINIA M ROMETTY SEE SCHEDULE O 3.0 0.0 X 0 0 0 ALAN D SCHNITZER SEE SCHEDULE O 5.0 0.0 X X 0 0 0 STEPHEN C SHERRILL SEE SCHEDULE O 5.0 0.0 X X 0 0 0 PETER J SOLOMON SEE SCHEDULE O 3.0 0.0 X 0 0 0 JOHN R STRANGFELD SEE SCHEDULE O 3.0 0.0 X 0 0 0 SCOTT M STUART SEE SCHEDULE O 7.0 0.0 X X 0 0 0 DOUGLAS A WARNER III SEE SCHEDULE O 6.0 0.0 X X 0 0 0 PETER A WEINBERG SEE SCHEDULE O 6.0 0.0 X X 0 0 0 36138314 0 1765414 9321 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCTION 31623606 ACCENTURE LLP 1345 AVENUE OF THE AMERICAS NY NY 10105 CONSULTING 10486074 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCTION 10146701 LEND LEASE US CONSTRUCTION 200 PARK AVENUE NY NY 10166 GENERAL CONSTRUCTION 8221785 MICHAEL ANTHONY CONTRACTING 161 RAILROAD AVENUE NEW HYDE PARK NY 11040 GENERAL CONSTRUCTION 5129938 161 232119000 585361000 7364296 817480000 MEDICAL CARE 622310 5251278000 5251278000 NON-GOVERNMENT SPONSORED RESEARCH 541711 170746000 170746000 5422024000 30917000 7147496 23769504 0 127752000 127752000 37958000 46233000 -8275000 0 -8275000 -8275000 1887590738 1384019738 503571000 503571000 503571000 0 0 0 0 0 0 0 0 0 CAFETERIA 722212 5035000 5035000 VENDOR DISCOUNTS 561439 713000 713000 SERVICES PROVIDED 561439 7245000 7245000 24348000 16511172 7836828 37341000 6930810000 5422024000 23658668 667647332 180500 180500 21258000 21258000 0 0 25849417 20717314 3762294 1369809 911327 804366 106000 961 2589059204 2544894476 14243238 29921490 168702498 166415449 538383 1748666 370194887 363402226 1018758 5773903 160087681 157094992 1316805 1675884 0 13759606 12745840 1010340 3426 1264882 1147836 116357 689 935326 935326 0 9337887 9337887 111371563 101678362 2286358 7406843 34957211 32923634 2033577 325513898 304357317 4528956 16627625 104725460 102839519 672084 1213857 13571828 13571828 130465337 103892687 26452199 120451 1752091 1723223 1794 27074 0 10001459 9911832 35929 53698 112663490 102868935 9794555 0 422308691 418107050 3714534 487107 54593768 54422198 37625 133945 PHARMACEUTICALS 1202542414 1202535546 2485 4383 MEDICAL/SURGICAL SUPPLIES 304530999 304521848 8649 502 EXPENSES OFFSETTING REVENUE -46233000 -46233000 UBIT EXPENSE 50576 50576 6144357000 6009303308 63159138 71894554 X 15573219 5642489 9930730 423224000 197290000 1051632000 1324503000 361795000 510406000 537985000 623746000 0 0 200000 100000 47069000 55017000 105324000 126425000 119081000 456894000 8589830000 4177500000 4473604000 4412330000 4095712000 4665943000 1862603000 2504522000 14280000 8549000 0 0 222741000 55527000 13315250000 14941252000 1139730000 1229458000 0 0 0 0 1115976000 1151455000 0 0 0 0 2013396000 2001615000 0 0 977230000 733882000 5246332000 5116410000 X 6625815000 8106650000 1443103000 1718192000 8068918000 9824842000 13315250000 14941252000 X 786453000 749964000 219507000 X false true X true true true X X 4 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 131624182 4 true 0 0 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES 131624082 3 true 0 0 MEMORIAL SLOAN-KETTERING CANCER CENTER 131924236 3 true 0 0 LOUIS V GERSTNER JR GRADUATE SCHOOL OF BIOMEDICAL SCIENCES 202212588 2 true 0 0 4 0 0 514556000 591422434 468105011 446134773 790884000 2811102218 0 0 514556000 591422434 468105011 446134773 790884000 2811102218 106360890 2704741328 100111000 190676000 123653294 129384000 154206000 698030294 0 0 3509132512 18186820782 0.77077 0.75417 X true false false false false false false false false false false false false false false false true false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SUPPORTED ORGANIZATIONS SUPPORT FROM THE SUPPORTING ORGANIZATIONS RELATE PRINCIPALLY TO THE SHARING OF CERTAIN FACILITIES, EQUIPMENT, PERSONNEL COSTS, EDUCATION, INSURANCE AND ALLOCATIONS. AMOUNTS DUE TO OR DUE FROM AFFILIATES RESULTING FROM THESE SERVICES DO NOT BEAR INTEREST. SUPPORTING ORGANIZATIONS NAME OF SUPPORTING ORGANIZATION EIN TYPE S.K.I. REALTY 13-3389586 12a MSK INSURANCE US 83-0363317 12a MSKCC PROTON INC. 35-2397819 12a MSKCC PROPERTIES, LLC. 35-2464610 12a RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false false true 432793 false true 502533 935326 false LOBBYING COSTS THE ORGANIZATION ENGAGES IN FEDERAL, STATE, AND LOCAL LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTATIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME, THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORTS FOCUS ON ISSUES RELATING TO PATIENT CARE, PUBLIC HEALTH, AND HOSPITAL OPERATIONS. PATIENT CARE AND PUBLIC HEALTH ISSUES MAY INCLUDE ACCESS TO CARE AND CANCER PREVENTION AND SCREENING, INCLUDING AS PART OF STATE BUDGET LEGISLATION. OUR ADVOCACY ON HOSPITAL OPERATIONS CENTERS ON ISSUES RELATING TO PROFESSIONAL LICENSURE AND CONTINUING EDUCATION, SCOPE OF PRACTICE, HOSPITAL STAFFING, AND HEALTH AND SAFETY REQUIREMENTS. ON OCCASION, THE CENTER ENGAGES IN LOCAL LOBBYING ON ISSUES RANGING FROM BUILDING ORDINANCES TO RADIATION CONTROL. THE CENTER ALSO INCURS COSTS FOR FEDERAL, STATE, AND LOCAL LOBBYING BY ASSOCIATIONS AND OTHER ORGANIZATIONS OF WHICH IT IS A MEMBER. PART II-B LINE 1(I) OTHER ACTIVITIES LOBBYING PORTION OF DUES PAID IN 2021 GREATER NEW YORK HOSPITAL ASSOCIATION $ 369,740 AMERICAN HOSPITAL ASSOCIATION 37,492 HEALTH CARE ASSOC. OF NYS 35,325 ALLIANCE OF DEDICATED CANCER CTRS 53,200 OTHERS 6,776 TOTAL $ 502,533 false false 1228619000 96214000 3089000 1327922000 1208893000 19598000 128000 1228619000 1123167000 59460000 26266000 1208893000 869056000 152114000 101997000 1123167000 802748000 52800000 13508000 869056000 0.42820 0.57180 false false 388332000 388332000 5565059000 2434081000 3130978000 115755000 92594000 23161000 2223347000 1635787000 587560000 297337000 15038000 282299000 4412330000 PRIVATE EQUITY & VENTURE CAP. 2504522000 F 2504522000 0 POSTRETIREMENT OBLIGATIONS 142436000 INSURANCE RESERVES 298156000 DEFERRED COMPENSATION 103122000 ASSET RETIREMENT OBLIGATION 38997000 DEFERRED GIFT ANNUITY 16442000 OTHER LIABILITIES 1889000 ROYALTY INTEREST LIABILITY 132840000 733882000 7699602000 749964000 46244000 796208000 6903394000 27416000 27416000 6930810000 6163263000 46322000 46322000 6116941000 27416000 27416000 6144357000 USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. PART XI LINE 2D RENTAL EXPENSES OFFSETS REVENUE $46,233,000 MMPC REV - SEPERATE 990 11,000 TOTAL $46,244,000 PART XII LINE 2D RENTAL EXPENSES OFFSETS REVENUE $46,233,000 MMPC EXP - SEPERATE 990 89,000 TOTAL $46,322,000 FIN 48 - LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. true true true true true true true false false false false false false false false false false true NONDISCRIMINATORY POLICY THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE: https://www.sloankettering.edu/gerstner/admissions/requirements ALL APPLICANTS TO THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES ARE CONSIDERED ON THE BASIS OF MERIT. THE SCHOOL DOES NOT DISCRIMINATE ON THE BASIS OF GENDER, RACE, COLOR, CREED, RELIGION, AGE, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS, MARITAL STATUS, SEXUAL ORIENTATION, OR CITIZENSHIP STATUS IN ACCORDANCE WITH INSTITUTIONAL POLICY AND IN COMPLIANCE WITH THE REQUIREMENTS OF THE CIVIL RIGHTS ACT, THE EDUCATION AMENDMENTS, THE REHABILITATION ACT, THE AGE DISCRIMINATION ACT, AND THE AMERICANS WITH DISABILITIES ACT. EXCISE TAX ON NET INVESTMENT INCOME THE LOUIS V GERSTNER JR, GRADUATE SCHOOL OF BIOMEDICAL SCIENCES DOES NOT MEET THE CRITERIA OF SECTION 4968 AND, THEREFORE, IS NOT SUBJECT TO THE EXCISE TAX ON NET INVESTMENT INCOME. Europe (Including Iceland and Greenland) 0 0 Program Services PATIENT CARE CONF 20596 Europe (Including Iceland and Greenland) 0 0 Program Services RESEARCH CONFERENCES 13474 Middle East and North Africa 0 0 Program Services PATIENT CARE CONFS 4727 East Asia and the Pacific 0 0 Program Services RESEARCH CONFRENCES 1316 North America 0 0 Program Services RESEARCH CONFRENCES 7382 Europe (Including Iceland and Greenland) 0 5 Program Services ADMIN SUPPORT 1072673 Middle East and North Africa 0 1 Program Services ADMIN SUPPORT 204387 Middle East and North Africa 0 2 Program Services MEDICAL SUPPORT 509533 East Asia and the Pacific 0 1 Program Services RESEARCH SUPPORT 63687 Europe (Including Iceland and Greenland) 0 4 Program Services RESEARCH SUPPORT 357532 South Asia 0 1 Program Services RESEARCH SUPPORT 26999 Central America and the Caribbean 0 0 Investments 3148653396 Europe (Including Iceland and Greenland) 0 0 Investments 21094339 Sub-Saharan Africa 0 0 Investments 63436653 0 14 0 14 3235466694 3235466694 true false true true true true INVESTMENTS BY REGION VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. true true X true X 500. true X 500. true true true false true true 23753035 23753035 0.00390 285277605 84924292 200353313 0.03260 309030640 84924292 224106348 0.03650 18655996 12000 18643996 0.00300 213879616 57959277 155920339 0.02540 2448884 2448884 0.00040 662298329 383401732 278896596 0.04540 241453 241453 897524278 441373009 456151268 0.07420 1206554918 526297301 680257616 0.11070 3426 3426 487521 13905 473616 0.00080 935018 935018 0.00150 69301 23800 45501 0.00010 3653 3653 1498919 37705 1461214 0.00240 false 69401293 2111787 1457200241 1914930588 -457730347 X true true 1 1 MEMORIAL HOSP FOR CANCER & ALLIED DIS 1275 YORK AVENUE NEW YORK NY 10065 www.mskcc.org 7002020H X X X X Urgent Care Center SEE PART V OF SCH H MEMORIAL HOSP FOR CANCER & ALLIED DIS 1 false false true X X X X X X X X X X 19 true false false true X www.mskcc.org/communityserviceplans X X true 19 true www.mskcc.org/communityserviceplans false true X 500. 500. X X X X X X true true X X X X true X SEE SCH H, PART V, SECTION C X www.mskcc.org/financial-assistance X SEE SCH H, PART V, SECTION C X X X X X X X true X false X X X X true X false false PART V FACILITY INFORMATION LINE 3E WE PRIORITIZED THE IDENTIFIED COMMUNITY HEALTH NEEDS BASED ON CERTAIN CRITERION AS OUTLINED IN THE CHNA AND LINKED THEM TO APPROPRIATE PROGRAMS AND ACTIVITIES AS DESCRIBED IN THE IMPLEMENTATION STRATEGIES POSTED TO OUR WEBSITE AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. LINE 3J MSK CONDUCTED A COMMUNITY HEALTH NEEDS ASSESSMENT DURING THE SECOND QUARTER OF 2019 TO DETERMINE THE CRITICAL CANCER-RELATED HEALTH NEEDS FACING RESIDENTS IN OUR 23-COUNTY CATCHMENT AREA IN NEW YORK, NEW JERSEY, AND CONNECTICUT. WE ANALYZED CANCER STATISTICS ON INCIDENCE, PREVALENCE, AND MORTALITY. WE ALSO REVIEWED KEY HEALTH TRENDS AMONG CANCER PATIENTS, MULTICULTURAL POPULATIONS, AND THE PUBLIC. LINE 5 TO ENGAGE THE BROAD COMMUNITY IN OUR HEALTH NEEDS ASSESSMENT, MSK HELD A SERIES OF COMMUNITY FORUMS IN MANHATTAN (HARLEM), BROOKLYN, LONG ISLAND, WESTCHESTER AND NEW JERSEY AS WELL AS AN ADDITIONAL WEBINAR PLACING SPECIAL FOCUS ON THE HEALTH NEEDS OF THE HISPANIC COMMUNITY. THE FORUMS WERE CONDUCTED TO CONNECT WITH REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS. THESE PRIVATE, NON-PROFIT, PUBLIC, AND GOVERNMENT AGENCIES WORK TO MEET COMMUNITY NEEDS WITH SERVICES AND RESOURCES THROUGHOUT NEW YORK CITY AND ITS SURROUNDING COMMUNITIES. REPRESENTATIVES FROM 38 COMMUNITY-BASED ORGANIZATIONS AND PARTNERS WHO SERVE A DIVERSE RANGE OF CLIENTS PARTICIPATED IN THESE FORUMS. SERVICES PROVIDED BY THE ORGANIZATIONS INCLUDE CANCER CARE SUPPORT, FOOD, MEDICAL, PSYCHOSOCIAL, IMMIGRATION ASSISTANCE, AND PRIMARY CARE SERVICES. COMMUNITY ORGANIZATIONS THAT PROVIDED INPUT ON MSK'S HEALTH NEEDS ASSESSMENT INCLUDE: AMERICAN CANCER SOCIETY, HUDSON VALLEY CHAPTER AMERICAN CANCER SOCIETY, LONG ISLAND CHAPTER AMERICAN CANCER SOCIETY, NEW JERSEY CHAPTER BERNARD'S TOWNSHIP HEALTH DEPARTMENT BROTHER TO BROTHER PROSTATE EDUCATION AND SUPPORT GROUP CANCER AND CAREERS CANCER SUPPORT TEAM COLETTE COYNE MELANOMA AWARENESS CAMPAIGN CUSTOM COLLABORATIVE EAST HARLEM COMMUNITY ALLIANCE FEEDING WESTCHESTER GOTHAM HEALTH HACKENSACK MERIDIAN HEALTH HARLEM CHILDREN'S ZONE HOFSTRA UNIVERSITY HUDSON VALLEY CASE MANAGEMENT SOCIETY JOHN J. BURN COMMUNITY CENTER LATINA SHARE LAURA FEINBLUM NUTRITION LEUKEMIA & LYMPHOMA SOCIETY, LONG ISLAND CHAPTER LEUKEMIA & LYMPHOMA SOCIETY, NEW JERSEY CHAPTER MARY'S PLACE BY THE SEA METROPOLITAN HOSPITAL MONMOUTH COUNTY HEALTH DEPARTMENT MOUNT VERNON CHAMBER OF COMMERCE NOSTRAND GARDENS CIVIC ASSOCIATION OCEAN COUNTY HEALTH ALLIANCE OPEN DOOR FAMILY MEDICAL CENTERS PLANNED PARENTHOOD PULSE RAICES SENIOR CENTER SHARE SISTERS UNITED IN HEALTH SPIRIT OF HOPE THE MEXICAN CONSULATE THE OFFICE OF BROOKLYN BOROUGH PRESIDENT - THEN ERIC ADAMS UNION COMMUNITY COUNCIL UNIONDALE CHAMBER OF COMMERCE LINE 7D SUMMARY FINDINGS OF MSK'S COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) WERE SENT TO COMMUNITY-BASED ORGANIZATIONS WITH WHOM WE WORK AND INVITED THEIR FEEDBACK. WE ALSO INCORPORATED THE CHNA INTO OUR ANNUAL COMMUNITY SERVICE PLAN (CSP) TO ADDRESS THE IDENTIFIED HEALTH NEEDS. THE CSP WAS DISTRIBUTED TO LOCAL ELECTED OFFICIALS AND OTHER COMMUNITY ORGANIZATIONS. THE CHNA WAS ALSO PUBLISHED ON OUR WEBSITE FOR PUBLIC INFORMATION AND INPUT AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. WE PUBLISHED THE CHNA IN 2019 WHEN THE ASSESSMENT WAS COMPLETED. WHILE THE NEXT CHNA CYCLE IS IN 2022, MSK WILL BE MAKING ANNUAL UPDATES TO ITS COMMUNITY SERVICE PLAN WHENEVER REQUIRED BY THE NEW YORK DEPARTMENT OF HEALTH. LINE 11 THE CHNA FOUND THAT MSK IS CURRENTLY ADDRESSING MANY AREAS OF NEED INCLUDING PREVENTION AND SCREENING EDUCATION, NUTRITION EDUCATION, TOBACCO CESSATION, FOOD INSECURITY, SCREENING GUIDELINES IN SPANISH, LANGUAGE ASSISTANCE FOR LIMITED ENGLISH PROFICIENCY PATIENTS, COLLABORATIVES INITIATIVES, TARGETED OUTREACH, AND SPANISH PROMOTIONS IN RELEVANT MEDIA. THROUGHOUT THE COVID-19 PANDEMIC, MSK HAS WORKED TO PROTECT AND ASSIST THE PUBLIC. MSK HAS UNDERTAKEN COVID-19 TESTING AND VACCINATION EFFORTS FOR ITS PATIENTS AND EMPLOYEES. TO MINISTER TO THE HEALTH CARE NEEDS OF THE BROADER COMMUNITY, THE INSTITUTION PARTNERED WITH OTHER GOVERNMENTAL AND COMMUNITY ORGANIZATIONS. SPECIFICALLY, MSK OPENED POP UP CLINICS AT LOCATIONS IN HARLEM AND BROOKLYN, AS WELL AS WORKING WITH NEW YORK CITY TO OPEN A PUBLIC VACCINATION SITE AT THE ABYSSINIAN BAPTIST CHURCH IN HARLEM. DURING THE PERIOD APRIL AND JULY, WE ADMINISTERED APPROXIMATELY 12,000 DOSES OF THE VACCINE TO THE HARLEM COMMUNITY. AN ADDITIONAL 440 DOSES WERE ALSO ADMINISTERED TO THE NASSAU COMMUNITY THROUGHOUT MARCH AND APRIL 2021 AT OUR FACILITY IN NASSAU COUNTY. THE ORGANIZATION HAS A WIDE RANGE OF PROGRAMS AND ACTIVITIES; AND CONTINUES TO DEVELOP NECESSARY PROGRAMS TO ADDRESS THE SIGNIFICANT NEEDS IDENTIFIED IN THE RECENTLY CONDUCTED CHNA. MSK'S RALPH LAUREN CENTER PROVIDES FREE AND DISCOUNTED CANCER CARE PREVENTION AND SCREENING, AS WELL AS HEALTH RELATED AND NUTRITIONAL EDUCATION AT NO COST TO THE COMMUNITY. MSK'S IMMIGRANT HEALTH AND CANCER DISPARITIES SERVICE (IHCD), ALSO ADDRESSES PREVENTION/SCREENING, NUTRITION EDUCATION AND REFERRALS TO IMMIGRANTS THROUGH THE ARAB HEALTH INITIATIVE, VENTANILLAS DE SALUD (HEALTH WINDOWS WITH MEXICAN CONSULATE), AND THE TAXI NETWORK. MSK'S IHCD ALSO RUNS THE FOOD TO OVERCOME DISPARITIES PROGRAM (F.O.O.D.), WHICH TACKLES FOOD INSECURITY AMONG UNDERSERVED CANCER PATIENTS BY PROVIDING NUTRITION EDUCATION AND FREE NUTRITIOUS FOODS THROUGH FOOD PANTRIES. F.O.O.D. PARTNERS WITH COMMUNITY-BASED ORGANIZATIONS, HOSPITALS AND OTHER AGENCIES TO CONDUCT RESEARCH ON THE IMPACT OF THE PROGRAM TO DECREASE FOOD INSECURITY AND INCREASE CANCER TREATMENT ADHERENCE AND PATIENT OUTCOMES. TO BENEFIT THE TOBACCO CESSATION, MSK'S TOBACCO TREATMENT PROGRAM (TTP) REDUCES TOBACCO-RELATED CANCER BURDENS AND ADDRESSES DISPARITIES THROUGH CLINICAL CARE, EDUCATION, TRAINING, COMMUNITY OUTREACH AND RIGOROUS INNOVATIVE TOBACCO USE PREVENTION AND TREATMENT RESEARCH. TTP PARTNERS WITH NYC DEPARTMENT OF HEALTH IN THE CITYWIDE TOBACCO CESSATION PARTNERSHIP. MSK'S MULTICULTURAL OUTREACH INITIATIVE AND HISPANIC COMMUNICATIONS INITIATIVE BOTH ADDRESS THE NEEDS EXPRESSED FOR TARGETED OUTREACH, COLLABORATIVE INITIATIVES WITH COMMUNITY-BASED ORGANIZATIONS, AND SPANISH ADVERTISING PROMOTION IN RELEVANT MEDIA. TO ADDRESS LANGUAGE ASSISTANCE FOR LIMITED ENGLISH PROFICIENCY PATIENTS, MSK HAS DEVOTED THREE PROGRAMS INCLUDING MSK'S LANGUAGE ASSISTANCE PROGRAM (WHICH PROVIDES TRAINING TO HEALTHCARE STAFF IN MEDICAL INTERPRETING AND CULTURAL/LINGUISTIC RESPONSIVENESS), THE LANGUAGE ASSISTANCE PROGRAM WHICH ENSURES ALL MSK'S PATIENTS AND FAMILIES ARE ABLE TO CONNECT TO HIGH QUALITY CARE THROUGH MEDICAL INTERPRETING AND TRANSLATION SERVICES, AND THE PATIENT & CAREGIVER ENGAGEMENT EDUCATIONAL MATERIALS WHICH TRANSLATES ALL EDUCATIONAL RESOURCES BY MSK TO ARABIC, CHINESE, FRENCH, HEBREW, ITALIAN, KOREAN, POLISH, RUSSIAN, AND SPANISH. TO ADDRESS PROVIDING SCREENING GUIDELINES IN SPANISH, MSK'S MARKETING & COMMUNICATIONS DEPARTMENT IS EXPANDING THE INSTITUTION'S EDUCATIONAL RESOURCES TO PROVIDE THE SPANISH-SPEAKING GENERAL PUBLIC WITH EASILY UNDERSTANDABLE RESOURCES AND RECOMMENDATIONS FOR PREVENTING CURRENT LEADING CANCERS AND FEATURE A GUIDE TO UNDERSTANDING CANCER SCREENINGS. MSK IDENTIFIED NEEDS THAT ARE BEYOND MSK'S SCOPE OF SERVICES INCLUDE HPV VACCINATION AND ADDRESSING THE LACK OF KNOWLEDGE ABOUT ACCESSING GENERAL SERVICES, IMMIGRATION CONCERNS AND HOW TO ACCESS THESE SERVICES. MSK PROVIDES REFERRALS TO EXTERNAL ORGANIZATIONS THAT RESPOND TO THESE NEEDS. ADDITIONAL INFORMATION ON IDENTIFIED NEEDS AND WHAT NEEDS ARE NOT BEING ADDRESSED TOGETHER WITH THE REASON WHY SUCH NEEDS ARE NOT BEING ADDRESSED CAN ALSO BE FOUND IN THE HOSPITAL'S MOST RECENT COMPREHENSIVE THREE-YEAR CSP AND CHNA REPORT POSTED AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. LINE 13B WE USE A 500% OF THE FEDERAL POVERTY LEVEL (FPL) AS AN ANNUAL INCOME GUIDELINE. HOWEVER, WE MAY QUALIFY PATIENTS FOR OUR FAP EVEN IF THEIR INCOME EXCEEDS THE 500%. THAT'S BECAUSE WE ALLOW A DEDUCTION FOR MONTHLY ROUTINE HOUSEHOLD BILLS BASED ON FAMILY SIZE. PATIENTS WITH A ZERO OR NEGATIVE BALANCE ARE THEREFORE ELIGIBLE FOR THE PROGRAM UNLESS THEY HAVE LARGE ASSETS NOT LINKED TO THEIR RETIREMENT OR EDUCATION. LINE 13G NEW PATIENTS WHO RESIDE IN NEW YORK OR NEW JERSEY MAY QUALIFY FOR FINANCIAL ASSISTANCE. EXISTING PATIENTS MAY QUALIFY FOR AID REGARDLESS OF WHERE THEY LIVE IN THE UNITED STATES. LINE 15E MSK IS COMMITTED TO PROVIDING FINANCIAL ASSISTANCE TO PATIENTS WITH THE GREATEST MEDICAL AND FINANCIAL NEEDS, INCLUDING UNINSURED AND UNDERINSURED PATIENTS WHO CANNOT AFFORD TO PAY FOR MEDICAL CARE OR WHO CANNOT ACCESS HEALTH INSURANCE. EACH APPLICATION FOR AID IS HANDLED CONFIDENTIALLY, IN COOPERATION WITH THE APPLICANT, AND IS DETERMINED BASED ON HOUSEHOLD INCOME AND FAMILY SIZE. HOSPITAL AND PHYSICIAN FEES ARE REDUCED OR TOTALLY FORGIVEN FOR QUALIFYING PATIENTS. TO HELP A BROAD RANGE OF PATIENTS, OUR INCOME ELIGIBILITY GUIDELINE FOR FREE CARE IS 500 PERCENT ABOVE THE FEDERAL POVERTY LEVEL, WELL ABOVE THE REQ 5 MSK MONMOUTH 480 RED HILL ROAD MIDDLE TOWN NJ 07748 EXTENSION CLINIC MSK BASKING RIDGE 136 MOUNTAIN VIEW BLVD BASKING RIDGE NJ 07920 EXTENSION CLINIC MSK BERGEN 225 SUMMIT AVENUE MONTVALE NJ 07901 EXTENSION CLINIC MSK CLINICAL GENETICS SERVICES 222 EAST 70TH STREET NEW YORK NY 10021 EXTENSION CLINIC BENDHEIM CENTER FOR INTEGRATED MEDICINE 1429 FIRST AVENUE NEW YORK NY 10021 EXTENSION CLINIC SCHEDULE H, PART VI PART 1, LINE 3A A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES IS ELIGIBLE FOR THE INSTITUTION'S FINANCIAL ASSISTANCE PROGRAM (FAP). THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. IN ADDITION, A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE "DISPOSABLE INCOME". MSK ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLE BELOW ILLUSTRATES THE INCOME GUIDELINE USED IN EVALUATING THE PATIENT'S FINANCIAL STATUS. FAMILY SIZE ALLOWED INCOME RESOURCE LEVELS 1 $ 64,400 $ 37,875 2 $ 87,100 $ 55,500 3 $109,800 $ 62,535 4 $132,500 $ 70,688 5 $155,200 $ 78,848 6 $177,900 $ 87,000 PART 1, LINE 3C THE MAXIMUM AMOUNT CHARGED TO PATIENTS DEEMED ELIGIBLE UNDER THE FAP FOR "EMERGENCY OR OTHER MEDICALLY NECESSARY CARE" IS THE AMOUNT THE INSTITUTION INITIALLY CONCLUDED A PATIENT CAN AFFORD TO PAY WHEN FINALIZING THE FAP APPLICATION. THIS AMOUNT IS DERIVED BY CALCULATING A PATIENT'S HOUSEHOLD "NET MONTHLY INCOMEDEDUCTING THE TOTAL AMOUNT OF ROUTINE MONTHLY BILLS. THE AMOUNT REMAINING IS WHAT WE CONSIDER THE PATIENT CAN PAY EACH MONTH. IF THE PATIENT'S HOUSEHOLD MONTHLY ROUTINE BILLS ARE MORE THAN OR EQUAL TO "NET MONTHLY INCOME", THE INSTITUTION ACCEPTS WHATEVER THE PATIENT'S INSURANCE PAYS AS PAYMENT IN FULL, (THE PATIENT WOULD NOT HAVE TO PAY ANYTHING OUT-OF-POCKET); UNLESS THE PATIENT HAS ASSETS SUCH AS A SECOND HOME, STOCKS, CERTIFICATE OF DEPOSITS, LARGE SAVINGS OR ANY OTHER ASSETS EXCLUDING RETIREMENT AND EDUCATION ACCOUNTS. PATIENTS WITH LARGE AMOUNTS OF ASSETS WHOSE ROUTINE MONTHLY BILLS ARE GREATER THAN THEIR "NET MONTHLY INCOME" MAY BE ELIGIBLE FOR REDUCED TIME AND PAYMENT ARRANGEMENT AND WOULD MAKE MONTHLY PAYMENTS (12 TO 18 MONTHS) TO PAY OFF THE AMOUNT THE INSTITUTION DETERMINED THEY CAN AFFORD TO PAY. ONCE THE FAP APPLICATION IS FINALIZED AND A PATIENT IS DEEMED ELIGIBLE TO PAY NOTHING OR A REDUCED TIME PAYMENT, THIS AGREEMENT IS EFFECTIVE FOR ONE YEAR AND INCLUDES THE PATIENT'S OUTSTANDING BALANCES. ALL PATIENTS ARE ADVISED OF MSK'S FAP, BUT AGAIN THE DETERMINATION IS ONLY DOCUMENTED IF THE PATIENT APPLIES FOR THE ASSISTANCE. PART I, LINE 7G MEMORIAL SLOAN KETTERING HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. THE RALPH LAUREN CENTER AT MEMORIAL SLOAN KETTERING CANCER CENTER WAS ESTABLISHED IN 2003 WITH GENEROUS FUNDING FROM THE RALPH LAUREN CORPORATE FOUNDATION AND THE LAUREN FAMILY TO ADDRESS SIGNIFICANT HEALTH DISPARITIES FOUND IN LOW-INCOME AND HISTORICALLY UNDERSERVED COMMUNITIES IN NEW YORK CITY. LOCATED IN HARLEM AND ASSISTING PEOPLE FROM ALL FIVE BOROUGHS, THE RALPH LAUREN CENTER (RLC) IS A MODEL FOR BROADENING ACCESS TO HIGH-STANDARD CANCER PREVENTION, DIAGNOSTICS, AND TREATMENT SERVICES. IN 2019, THE RLC WAS INCORPORATED WITHIN MSK, CREATING IMPORTANT OPPORTUNITIES TO EXPAND AND INCREASE SUSTAINABLE BENEFITS TO UNDERSERVED NEW YORKERS AFFECTED BY CANCER. MSK ALSO MERGED ITS BREAST EXAMINATION CENTER OF HARLEM INTO THE RLC THAT YEAR, STREAMLINING EFFORTS IN ONE CONVENIENT LOCATION. MSK RALPH LAUREN CENTER PROVIDES CANCER PREVENTION, SCREENING, DIAGNOSIS, TREATMENT, AND SOCIAL SERVICES, AS WELL AS FINANCIAL COUNSELING AND A FOOD PANTRY SUPPLEMENTED WITH NUTRITIONAL COUNSELING. RLC'S SCOPE OF SERVICES INCLUDE BREAST CANCER EVALUATION, DIAGNOSTIC AND TREATMENT SERVICES, INCLUDING CHEMOTHERAPY, FOR MOST CANCERS AND BLOOD DISEASES, AND SCREENING SERVICES FOR BREAST, CERVICAL, COLON, PROSTATE AND LUNG CANCER AND SMOKING CESSATION PROGRAM. RLC IS STAFFED BY MEDICAL ONCOLOGISTS, A BREAST SURGEON, APP'S, REGISTERED NURSES, PATIENT CARE TECHNICIANS, A DIETICIAN/NUTRITIONIST, RADIOLOGY TECHNOLOGISTS, AND LAB TECHNICIANS. REFERRALS TO CLINICIANS, PROGRAMS, AND FACILITIES WITHIN MEMORIAL HOSPITAL ARE COORDINATED FOR PATIENTS REQUIRING SUCH SERVICES. TO-DATE RLC HAS MANAGED MORE THAN 180,000 PATIENT VISITS SINCE ITS FOUNDING. APPROXIMATELY 15,500 VISITS WERE MADE BETWEEN APRIL 1, 2019 AND DECEMBER 31, 2021 WHEN RLC TRANSITIONED TO MSK. MORE THAN 2,000 FINANCIAL ASSESSMENTS WERE ALSO RECORDED, DURING THE PERIOD APRIL 1, 2019 AND DECEMBER 31, 2021. MEMORIAL SLOAN KETTERING'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT IS COMMITTED TO THE URGENT AS WELL AS ROUTINE CARE OF PATIENTS WITH CANCER. OUR PSYCHIATRISTS AND PSYCHOLOGISTS HAVE EXPERTISE IN ASSISTING PATIENTS WITH THE SPECTRUM OF PSYCHIATRIC AND BEHAVIORAL ISSUES THAT CAN ARISE DURING DIAGNOSIS AND TREATMENT. THE DEPARTMENT ALSO WORKS TO DEEPEN ITS UNDERSTANDING AND EXPAND TREATMENT OPTIONS FOR ONCOLOGY PATIENTS AROUND THE GLOBE THROUGH CLINICAL TRIALS, RESEARCH, AND OTHER MEANS. TO ACCOMPLISH THESE GOALS, THE DIVISION OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. FUNDING FOR THE MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MSK, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENT'S OVERALL CLINICAL AND TRAINING ACTIVITIES. SERVICES PROVIDED INCLUDE CONSULTATIONS AND EVALUATION, PSYCHOTHERAPY, MEDICATION MANAGEMENT AND PHARMACOTHERAPY, SUPPORTIVE COUNSELING, SMOKING CESSATION, HYPNOTHERAPY, VARIOUS DIAGNOSTIC TESTS, AND OTHERS. DURING 2021, THE DEPARTMENT EXPERIENCED 32,600 INPATIENT AND OUTPATIENT ENCOUNTERS WITH 1,739 PATIENTS TREATED THROUGH THE SMOKING CESSATION PROGRAM. APPROXIMATELY $4.49M WAS EXPENDED BY THE DEPARTMENT TO SUPPORT ITS COMMUNITY BENEFIT-RELATED PROGRAMS, OF WHICH $1.78M OR 40%, WERE INCURRED FOR SUBSIDIZED CLINICAL CARE. AT MSK WE BELIEVE IN CARING FOR THE WHOLE PERSON NOT JUST THE DISEASE OR SYMPTOM. INTEGRATIVE MEDICINE WEAVES NATURAL TREATMENTS SUCH AS ACUPUNCTURE, MASSAGE, AND YOGA INTO OUR OVERALL CARE PLAN. ALL OF OUR HOLISTIC HEALTH SERVICES AND PROGRAMS ARE BASED ON THE LATEST SCIENTIFIC EVIDENCE. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS. DURING 2021, WE SERVICED 7,903 PATIENT VISITS. THESE CLINICAL SERVICES INCLUDED MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION AND GUIDED IMAGERY, KARATE AND DANCE THERAPY. WE ALSO PROVIDED EXTENSIVE EDUCATION FOR PATIENTS AND CAREGIVERS DURING BEDSIDE AND GROUP VISITS. IN ADDITION, WE OFFER OUTPATIENT ACUPUNCTURE CONSULTATIONS TO ANYONE IN THE COMMUNITY AT NO COST TO THEM. THESE CONSULTATIONS ADVISED CLIENTS ON HOW ACUPUNCTURE BENEFIT THEIR CONDITION BASED ON THEIR SPECIFIC THERAPEUTIC NEEDS. THERE WERE 91 ACUPUNCTURE CONSULTATIONS PROVIDED IN 2021. THE DEPARTMENT INCURRED $1.53M IN PERSONNEL COST TO DELIVER COMMUNITY BENEFIT-RELATED PROGRAMS. $0.60M OR 39% WERE SPENT ON SUBSIDIZED CLINICAL CARE. PART I, LINE 7, COL (F) THE BAD DEBT EXPENSE WAS NOT INCLUDED ON LINE 25 IN ACCORDANCE WITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP). PART I, LINE 7 FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTION'S ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES, AND AS DESCRIBED IN OTHER SECTIONS OF THIS DOCUMENT. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED IN THE TABLE ON LINE 7, WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND THE UNREIMBURSED MEDICAID COST WERE BASED ON A COST-TO-CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE OBTAINED FROM THE STEP-DOWN OF COSTS PREPARED AS PART OF THE NEW YORK STATE INSTITUTIONAL COST REPORT. TO ARRIVE AT THE AMOUNTS REPORTED IN THE TABLE ON LINE 7, ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT-SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTION'S COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH, SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENT INSTITUTIONAL FUNDS, AS WELL AS COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD-PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. AS INDICATED EARLIER, MSK'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL SERVICES AND OTHER QUALIFYING SUBSIDIZED COMMUNITY BENEFIT PROGRAMS TO PATIENTS. SUBSIDIZED CANCER SCREENINGS ARE ALSO OFFERED THROUGH OTHER COMMUNITY PROGRAMS PROVIDED BY THE INSTITUTION. THE COST ASSOCIATED WITH THESE PATIENTS' CARE ARE REPORTED IN THE TABLE ON LINE 7, BASED ON PATIENT CARE COST TO CHARGE RATIO, WHERE APPLICABLE. ALL SALARY EXPENSES RELATED TO OTHER SUBSIDIZED PATIENT CARE BY ATTENDING PHYSICIANS, CLINICAL AND RESEARCH FELLOWS AND NURSE PRACTITIONERS ARE ALSO REPORTED IN THE TABLE ON LINE 7G. PART II MSK ENGAGES IN AND SUPPORTS COALITION-BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR VARIOUS TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. PART III, LINE 2 THE AMOUNT ON LINE 2 OF PART III IS THE ACTUAL 2021 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISIONS FOR BAD DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCULATED FOR EACH TYPE OF PATIENT CARE ACTIVITY: INPATIENT, OUTPATIENT, AND PHYSICIAN. PART III, LINE 3 PATIENTS CAN PURSUE FINANCIAL ASSISTANCE THROUGH MSK'S FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS FOUND TO HAVE THE APPROPRIATE RESOURCES TO PAY FOR HEALTH SERVICES AND DOES NOT OR CHOOSES NOT TO PARTICIPATE IN AVAILABLE HEALTH BENEFIT PROGRAMS, THE INSTITUTION WILL BEGIN COLLECTION PROCEEDINGS IN ACCORDANCE WITH THE INSTITUTION'S POLICY. ONCE DEEMED UNCOLLECTABLE, THE CHARGES ARE CLASSIFIED AS BAD DEBTS AND ARE CHARGED OFF AS SUCH. THE AMOUNT ON LINE 3, OF PART III, REFLECTS THE COST OF THESE ACCOUNTS AS CALCULATED BASED ON THE COST-TO-CHARGE RATIO METHODOLOGY DESCRIBED EARLIER. IN DETERMINING THE AMOUNT THAT REASONABLY COULD BE ATTRIBUTABLE TO PATIENTS WHO LIKELY WOULD QUALIFY FOR FINANCIAL ASSISTANCE UNDER THE INSTITUTION'S POLICY, THE INSTITUTION REVIEWED THE CASES THAT WERE CLOSED WITH AN "INCOMPLETE" STATUS IN THE FINANCIAL ASSISTANCE PROGRAM DURING 2017 THROUGH 2021. THE INSTITUTION THEN COMPARED THESE CASES AGAINST THE BAD DEBT WRITE-OFFS FROM 2021. PART III, LINE 4 THE INSTITUTION FOLLOWS GENERALLY ACCEPTED ACCOUNTING PRINCIPLES IN REPORTING ON BAD DEBT EXPENSES. THEREFORE, A DETAILED DESCRIPTION OF THE BAD DEBT POLICY IS NOT REQUIRED IN THE FOOTNOTES TO THE AUDITED FINANCIAL STATEMENTS. PART III, LINE 8 THE MEDICARE LOSS REFLECTS LOSSES FROM BOTH HOSPITAL AND PHYSICIANS' ACTIVITY. PHYSICIAN REVENUE IS SHOWN AS OTHER REVENUE ON THE MEDICARE COST REPORT. COSTS DISALLOWED BY THE MEDICARE PROGRAM, BUT WHICH AR INCURRED IN PROVIDING CARE TO MEDICARE BENEFICIARIES HAVE BEEN INCLUDED. PART III, LINE 9B THE INSTITUTION DOES NOT PURSUE COLLECTIONS FROM PATIENTS APPLYING FOR FINANCIAL ASSISTANCE. IF, HOWEVER, COLLECTIONS WERE INITIATED, THE EFFORT IS IMMEDIATELY SUSPENDED WHEN THE PATIENT APPLIES FOR FINANCIAL ASSISTANCE. IF THE PATIENT QUALIFIES FOR THE FAP WITH ZERO FEE PAYMENT, THE INSTITUTION ACCEPTS AS FULL SETTLEMENT ANY AMOUNT PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. ADDITIONALLY, IF A PATIENT QUALIFIES FOR A TIME PAYMENT PLAN (TPP), ALL OTHER CHARGES APART FROM THE AGREED TPP AMOUNT IS WRITTEN OFF AS FINANCIAL ASSISTANCE. FOR EXAMPLE, IF THE AGREEMENT CALLS FOR THE PATIENT TO MAKE AN ANNUAL PAYMENT OF $1,200 ($100 MONTHLY), THEN ALL OTHER CHARGES ACCRUING TO THE PATIENT ARE CANCELED AND WRITTEN OFF AS FINANCIAL ASSISTANCE. ANNUALLY, THE PATIENT'S CASE IS RE-EVALUATED AND ADJUSTMENTS MADE BASED ON CHANGING CIRCUMSTANCES. PART VI, LINE 2 THE CHNA IS THE MEANS BY WHICH THE INSTITUTION ASSESSES THE HEALTH NEEDS OF THE COMMUNITY SEE PART V, SECTION B. PART VI, LINE 3 SINCE 1987, MSK HAS HAD A FINANCIAL ASSISTANCE PROGRAM IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. FINANCIAL COUNSELORS WORK WITH PATIENTS AND INSURANCE COMPANIES INCLUDING MEDICARE AND MEDICAID TO HELP THE PATIENTS TO ACCESS SERVICES. THOSE WHO DO NOT QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE, OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES ABOVE INSURANCE REIMBURSEMENT, MAY OBTAIN HELP THROUGH THE INSTITUTION'S FAP IF THEY ARE ELIGIBLE. THE PREMISE OF THE PROGRAM IS THAT ALL PATIENTS ARE EXPECTED TO CONTRIBUTE TO THEIR CARE BASED ON THEIR FINANCIAL ABILITY. THE FAP EMPLOYS SEVERAL STRATEGIES TO INCREASE PATIENTS' AWARENESS OF THE PROGRAM. DURING THE REGISTRATION PROCESS, FINANCIAL INTERVIEWERS EDUCATE PATIENTS ON THE VARIOUS PROGRAMS AVAILABLE TO THEM, INCLUDING GOVERNMENTAL PROGRAMS AND THE FINANCIAL ASSISTANCE PROGRAMS. MSK PERSONNEL SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS ALSO MENTIONED IN EVERY STATEMENT AND LETTER THAT SENT TO A PATIENT. MOREOVER, THE FAP IS AGAIN MENTIONED IN EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS, HE/SHE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND RETROACTIVE FAP COVERAGE WOULD BE GIVEN IF A PATIENT IS DETERMINED ELIGIBLE FOR ASSISTANCE. INFORMATION ABOUT THE FINANCIAL ASSISTANCE PROGRAM IS ALSO AVAILABLE ON THE INSTITUTION'S WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE OR BY CALLING OUR DEDICATED FINANCIAL ASSISTANCE LINE AT (212) 639-3810. PART VI, LINE 4 MSK'S INPATIENT HOSPITAL IS IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE FIVE BOROUGHS OF NEW YORK CITY, LONG ISLAND, SOUTHERN NEW YORK STATE, NEW JERSEY, AND SOUTHWESTERN CONNECTICUT. A TOTAL OF 201,586 PATIENTS WERE SEEN AT MSK'S FACILITIES IN 2021, INCLUDING 184,175 (91.4 PERCENT) PATIENTS FROM THE TRI-STATE AREA (NY, NJ, CT); 16,994 (8.4 PERCENT) PATIENTS FROM OTHER PARTS OF THE UNITED STATES; AND 417 (0.2 PERCENT) PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 24,142 ADMISSIONS TO OUR HOSPITAL WITH 171,355 RELATED PATIENT DAYS AND 904,743 OUTPATIENT VISITS AT OUR COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. PART VI, LINE 5 MSK'S MISSION IS TO LEAD IN THE PREVENTION, DIAGNOSIS, TREATMENT, AND CURE OF CANCER THROUGH PROGRAMS OF EXCELLENCE IN COST-EFFECTIVE RESEARCH, EDUCATION, OUTREACH AND PATIENT CARE. OUR CLINICAL RESEARCHERS HAVE DEVELOPED NUMEROUS CHEMOTHERAPY AND RADIATION THERAPY REGIMENS, SURGICAL METHODS, AND DIAGNOSTIC TECHNIQUES THAT ARE NOW CONSIDERED THE STANDARD OF CARE FOR PATIENTS AROUND THE WORLD. WE FOCUS ON MULTIDISCIPLINARY CARE, WHERE EXPERTS FROM MANY FIELDS OF MEDICINE COME TOGETHER TO DEVELOP THE BEST TREATMENTS FOR INDIVIDUAL PATIENTS AND FOR THE TREATMENT OF PATIENTS WITH ALL TYPES OF CANCER. THIS HAS ALLOWED US TO BE AT THE FOREFRONT OF DEVELOPING TREATMENTS THAT ARE MORE EFFECTIVE AT TREATING CANCER, WHILE AT THE SAME TIME SPARING MANY PATIENTS FROM THE MOST SERIOUS SIDE EFFECTS OF TREATMENT. OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITY'S UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2021, MEMORIAL SLOAN KETTERING SPENT $662.3M IN SUPPORT OF ITS RESEARCH MISSION, OF WHICH $241.0M WAS SPONSORED BY GOVERNMENTAL AND OTHER NON-PROFIT ORGANIZATIONS, $142.4M FROM PHILANTHROPY, AND $278.9M FROM THE INSTITUTION'S FUNDS. EDUCATION AND TRAINING ARE KEY COMPONENTS OF MEMORIAL SLOAN KETTERING'S MISSION AND IMPORTANT EXAMPLES OF HOW THE INSTITUTION MAKES CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSK ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING, THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MSK SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS, MEMORIAL SLOAN KETTERING STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. IN 2021, THE ORGANIZATION ESTABLISHED THE OFFICE OF HEALTH EQUITY (OHE) TO ADDRESS CANCER DISPARITIES THAT EXIST DUE TO RACIAL, ETHNIC, CULTURAL, OR SOCIOECONOMIC BARRIERS. THROUGH A PATIENT CENTRIC FOCUS, THE OHE IS RESPONSIBLE FOR LEADING PATIENT CARE AND RESEARCH ACTIVITIES INCLUDING THE CANCER HEALTH EQUITY RESEARCH PROGRAM (CHERP) AND CANCER EQUITY PROGRAMS. INTEGRAL TO OHE'S ROLE IS THE DEVELOPMENT OF HEALTH EQUITY RESEARCH AND EDUCATION AND TRAINING. AS SUCH THE OHE HAS IMPLEMENTED RECRUITING AND TRAINING INITIATIVES ACROSS THE INSTITUTION. THE OBJECTIVE OF THESE TRAINING PROGRAMS IS TO ENHANCE THE DIVERSITY OF FUTURE CANCER RESEARCH WORKFORCE BY PROVIDING MINORITY STUDENTS WITH EXPOSURE TO CUTTING-EDGE CANCER RESEARCH WITH RENOWNED MENTORS. THE RESEARCH PROGRAM IS FOCUSED ON HAVING DIVERSE POPULATIONS MORE EQUALLY REPRESENTED IN CANCER CLINICAL RESEARCH AND DEVELOPING A BETTER UNDERSTANDING OF THE DIFFERENCES IN CANCER INCIDENCE AND CANCER OUTCOMES EXPERIENCED BY GROUPS TRADITIONALLY UNDERREPRESENTED IN CLINICAL RESEARCH. THE OHE RESEARCH PROGRAM IS ALSO FOCUSED ON INCREASING ENROLLMENT OF UNDERREPRESENTED GROUPS ONTO CLINICAL TRIALS AT MSK. THE OHE PROVIDES FUNDING FOR THESE PROGRAMS ALLOWING MINORITY GROUPS WHO ARE UNDERREPRESENTED IN MEDICINE OPPORTUNITIES TO PARTICIPATE IN THE NATIONAL CANCER INSTITUTE'S MEDICAL STUDENTS SUMMER FELLOWSHIP PROGRAM. THE OHE ALSO COORDINATES A SIX-WEEK SUMMER EXPOSURE PROGRAM TO EXPOSE MINORITY HIGH SCHOOL STUDENTS TO CAREERS IN MEDICINE AND RESEARCH. MEMORIAL SLOAN KETTERING UTILIZED $213.9M OF THE INSTITUTION'S RESOURCES DURING 2021 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE CONSIDER VITAL, GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. $58.0M OF THE AMOUNT WAS SPONSORED BY GOVERNMENTAL AND OTHER REVENUE SOURCES AND $155.9M FROM THE INSTITUTION'S GENERAL FUND. THE INSTITUTION HAS A BOARD FOR EACH OF THE SEVEN ENTITIES. AS OUTLINED IN SCHEDULE O, THERE IS A TOTAL OF 114 BOARD MEMBERS. MANY ARE MEMBERS OF MORE THAN ONE ENTITY'S BOARD AND THEREFORE ARE COUNTED MORE THAN ONCE. THE GOVERNING BODY IS COMPRISED OF INDEPENDENT BOARD MEMBERS FROM THROUGHOUT THE UNITED STATES. MSK DOES NOT EXTEND MEDICAL STAFF PRIVILEGES TO COMMUNITY-BASED PHYSICIANS. ALL PHYSICIANS ARE ON STAFF AND ARE EMPLOYEES OF MSK, WITH LIMITED EXCEPTIONS. IN ITS PURSUIT TO FURTHER IMPROVE PATIENT CARE, MEDICAL EDUCATION, AND RESEARCH, THE INSTITUTION REINVESTS ANY SURPLUS FUNDS IN THE INSTITUTION'S POOL OF RESERVES. THESE RESERVES GENERATE INCOME TO SUPPORT FUTURE OPERATIONS AND RESTRICTED FUND SPENDING. BY PROVIDING FUNDING FOR OPERATIONS AND CAPITAL PROJECTS, IMPROVEMENTS TO PATIENT CARE, MEDICAL EDUCATION, AND RESEARCH ARE MADE POSSIBLE. COVID-19 ON MARCH 11, 2020, THE WORLD HEALTH ORGANIZATION DESIGNATED THE COVID-19 OUTBREAK AS A GLOBAL PANDEMIC. FEDERAL, STATE AND LOCAL GOVERNMENT POLICIES RESULTED IN A SUBSTANTIAL PORTION OF THE POPULATION REMAINING AT HOME AND FORCED THE CLOSURE OF CERTAIN BUSINESSES. THESE ACTIONS PRESENTED UNPRECEDENTED CHALLENGES TO ALL, INCLUDING THE MEDICAL COMMUNITY AS THEY GRAPPLED TO CONTAIN THE DE true AMERICAN CANCER SOCIETY 3380 CHASTAIN MEADOW PKY KENNESAW GA 30144 131788491 501c(3) 70000 CANCER AWARENESS LEUKEMIA & LYMPHOMA SOCIETY 3 INTERNATIONAL DR RYE BROOK NY 10573 135644916 501c(3) 45000 CANCER AWARENESS SUSAN G KOMEN FOR THE CURE 901 E ST NW WASHINGTON DC DC 20004 751835298 501c(3) 20000 CANCER AWARENESS WESTCHESTER COUNTY ASSOCIATION 1133 WESTCHESTER AVE WHITE PLAINS NY 10604 131737011 501c(4) 25000 CANCER AWARENESS LONG ISLAND NETS 168 39TH STREET BROOKLYN NY 11232 222219916 10000 CANCER AWARENESS GILDA'S CLUB WESTCHESTER 80 MAPLE AVE WHITE PLAINS NY 10601 133939823 501c(3) 8000 CANCER AWARENESS 4 2 STIPENDS 347 21258000 Form 990, Schedule I FOR THE YEAR 2021, THE AMOUNT IS FOR STIPENDS PAID TO 184 RESEARCH FELLOWS AND 163 GRADUATE SCHOOL STUDENTS. EDUCATION AND TRAINING INCLUDE CLASSROOM INSTRUCTION WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. X X true true X X X X X true true false false false false false true true true CRAIG B THOMPSON MD PRESIDENT & CEO 1791351 0 360000 0 533175 0 39200 0 241757 0 2965483 0 16500 0 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 976596 0 594840 0 1159822 0 39200 0 47825 0 2818283 0 16500 0 BABAK MEHRARA MD CHIEF ATTENDING-SURGERY 2484922 0 0 0 85085 0 31200 0 46046 0 2647253 0 8250 0 JEFFREY DREBIN MD CHAIRMAN ATTENDING-SURGERY 2255135 0 0 0 145583 0 31200 0 48249 0 2480167 0 8250 0 JOSEPH DISA MD ATTENDING PLASTIC SURGERY 2109915 0 0 0 18312 0 31200 0 51453 0 2210880 0 8250 0 ROBERT KURTZ MD ATTENDING 396037 0 0 0 1628027 0 27852 0 21745 0 2073661 0 0 0 DAVID JONES MD CHIEF ATTENDING-SURGERY 1983090 0 0 0 20157 0 31200 0 19410 0 2053857 0 8250 0 KATHRYN MARTIN EVP & COO 1427165 0 287106 0 46218 0 39200 0 46372 0 1846061 0 16500 0 MICHAEL HARRINGTON EVP & CFO 1436288 0 288400 0 49953 0 31200 0 32139 0 1837980 0 8250 0 SIMON POWELL MD DIRECTOR 1296653 0 267787 0 137926 0 31200 0 36251 0 1769817 0 8250 0 LISA DEANGELIS MD PHYSICAN IN CHIEF 1273347 0 247692 0 28391 0 31200 0 44002 0 1624632 0 8250 0 JOAN MASSAGUE PHD DIRECTOR 1031226 0 270994 0 166070 0 31200 0 43298 0 1542788 0 8250 0 JORGE LOPEZ ESQ EVP GENERAL COUNSEL 950745 0 337089 0 19298 0 31200 0 49159 0 1387491 0 8250 0 KERRY BESSY SVP-CHIEF HR OFFICER 703818 0 510773 0 46388 0 39200 0 42157 0 1342336 0 16500 0 KENNETH MANOTTI SVP DEVELOPMENT 892932 0 315620 0 42085 0 31200 0 36041 0 1317878 0 8250 0 ROXANNE TAYLOR SVP CHIEF MARKT/COMM 750009 0 375000 0 24663 0 31200 0 6974 0 1187846 0 8250 0 DEBRA BERNS ESQ SVP CHIEF RISK OFFICER 712890 0 261000 0 13565 0 31200 0 17103 0 1035758 0 8250 0 ERIC M COTTINGTON PHD SVP RESEARCH AND TECHNOLOGY 636930 0 261209 0 51999 0 38364 0 35605 0 1024107 0 32500 0 FREDRICK GROVES EVP HOSPITAL ADMINISTRATION 635335 0 251387 0 54063 0 31200 0 34276 0 1006261 0 8250 0 MARK SVENNINGSON SVP FINANCE 689445 0 126002 0 34700 0 39200 0 33817 0 923164 0 16500 0 EDWARD MAHONEY SVP FACILITIES MANAGEMENT 564736 0 244312 0 28573 0 27089 0 22696 0 887406 0 16500 0 CLAUS JENSEN EVP CHIEF DIGITAL OFFICER 390333 0 288400 0 9635 0 26923 0 16511 0 731802 0 8250 0 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL 439477 0 89116 0 12775 0 30980 0 28006 0 600354 0 7880 0 PATRICIA C SKARULIS FRMR SVP CHIEF INFORMATION 0 0 0 0 377770 0 0 0 6251 0 384021 0 0 0 AVICE MEEHAN FORMER SVP CH COMM OFFICER 0 0 0 0 198979 0 0 0 11714 0 210693 0 0 0 Supplemental Compensation Information SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4A - INCLUDED IN FORM 990 IS SEVERANCE PAY: AVICE MEEHAN, SVP & CHIEF COMMUNICATION OFFICER, OF $201,688. TERMINATED IN MAY 2019. PATRICIA SKARULIS, SVP & CHIEF INFORMATION OFFICER, OF $379,001. TERMINATED IN DECEMBER 2019 LINE 4b-INCLUDED IN FORM 990: JASON KLEIN WAS PAID $1,073,126 AS PART OF A DEFERRED COMPENSATION AGREEMENT. DR. ROBERT KURTZ WAS PAID $1,617,694 AS PART OF HIS RETIREMENT PLAN LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 SEE PART VI false false false C NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 SEE PART VI false false false D NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2017-12-20 335567386 SEE PART VI false false false A 66000000 0 80000000 0 0 0 0 0 0 0 80000000 0 2013 true false true true B 18702374 0 110239999 0 0 0 155282 0 0 110009717 75000 0 2017 false false true true C 76125000 0 145000000 0 0 0 72861 0 0 144627139 300000 0 2018 false false true true D 11550000 0 339194534 0 0 0 2262236 0 0 245499309 91432989 0 2019 true false true true A false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true B false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true C false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true D false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true A false false false true false false 0 false 0 false true B false false false true false false 0 false 0 false true C false false false true false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true PART I, COLUMN (F) DESCRIPTION OF PURPOSE 2013 SERIES BONDS (DASNY)- CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 SERIES BONDS ISSUED 9/2/2010. 2016 SERIES BONDS (DASNY) - CUSIP #000000000: 2016 SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES BONDS (NJEDA) - CUSIP #000000000: 2016 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. 2017 SERIES BONDS (DASNY)- CUSIP #000000000: 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS ISSUED JULY 16, 2015 AND CONSTRUCT VARIOUS FACILITIES. 2019 SERIES BONDS (DASNY) - CUSIP #64990GVG4: 2019 SERIES BONDS WERE USED TO REIMBURSE EXPENDITURES INCURRED TO CONSTRUCT A PATIENT CARE FACILITY. PART II LINE 3 - THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) - ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BONDS FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. THE 2013 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON JUNE 21, 2019. THE DASNY 2016 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON APRIL 14, 2021. THE NJEDA 2016 SERIES BONDS REBATE CALCULATIONS WERE PERFORMED ON JULY 6, 2022. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64990GVG4 2019-11-01 342248699 SEE PART VI false false false A 0 0 342248699 0 0 0 2248699 0 0 340000000 0 0 2019 false false true true A false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true A false true false false false false 0 false 0 false true A true SIMON POWELL MD DIRECTOR MORTGAGE X 1000000 100000 false true true 100000 DR T LINDSTEN SEE PART V BELOW 315343 FAMILY EMPLOYMENT false MEMORIAL MEDICAL CARE PC SEE PART V 89000 MANAGEMENT AGREEMENT false LOANS TO/FROM INTERESTED PARTIES To aid in the organization's recruitment and retention of physicians and other professional staff, the organization offers mortgage loans to eligible staff under a program approved by a committee of the Board. DR. SIMON POWELL IS A DIRECTOR OF MSK PROTON INC. AND A HOUSING RELATED LOAN WAS PROVIDED TO HIM IN 2012 BY MEMORIAL SLOAN KETTERING CANCER CENTER. BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS 1. DR. CRAIG THOMPSON IS THE PRESIDENT OF THE INSTITUTE. HIS SPOUSE IS A LABORATORY MEMBER FOR SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION FOR 2021 WAS $315,343. 2. LISA DEANGELIS M.D. IS THE PHYSICIAN-IN-CHIEF AND CHIEF MEDICAL OFFICER OF THE ORGANIZATION. SHE IS A 75% OWNER OF MEMORIAL MEDICAL CARE PC (MMPC). MMPC IS A SECTION 501(C)(3)TAX-EXEMPT CAPTIVE MEDICAL GROUP. MMPC WAS ORGANIZED TO PROVIDE SPECIALIZED SERVICES TO CERTAIN BONE MARROW TRANSPLANT PATIENTS OF THE HOSPITAL. THE PC AND THE HOSPITAL HAVE A MANAGEMENT AGREEMENT WHERE THERE IS NO NET COST TO THE HOSPITAL FOR THE SERVICE. THE HOSPITAL PROVIDES AND CHARGES THE PC FOR THE SERVICES RENDERED. THE AMOUNT REPORTED IN PART IV $89,000 IS THE COST OF SUCH SERVICES FOR THE YEAR. THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTION'S REVENUE. THE PURCHASES OF GOODS OR SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES NORMALLY CHARGED TO OTHERS. X 363 27639996 MARKET VALUE false true false PART I INCLUDED IN THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $20,275,700. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. PART VI, LINE 2 FOR THE TAX YEAR 2021, THE FOLLOWING BUSINESS RELATIONSHIPS WERE REPORTED: 1. DIRECTORS ELLEN V. FUTTER AND PETER J. SOLOMON 2. DIRECTORS ALEXANDER T. ROBERTSON AND CLIFTON S. ROBBINS 3. DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE 4. DIRECTORS WILLIAM FORD AND HENRY FERNANDEZ. PART VI, LINES 6-7 THE ARTICLES OF INCORPORATION AND BY-LAWS WERE REVIEWED TO DETERMINE THAT THE SUPPORTED ORGANIZATIONS OUTLINED IN SCHEDULE-A HAVE THE POWER TO ELECT OR APPOINT MEMBERS TO THE BOARD OF THE SUPPORTING ORGANIZATIONS. MEMORIAL SLOAN-KETTERING CANCER CENTER, EIN 13-1924236, (MSK), IS THE SINGLE MEMBER OF THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM LLC, PCCTC, WHO HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES AND MSKCC PROTON, INC. WHO HAS ALSO ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES EIN 13-1624082, (MEM), IS THE SINGLE MEMBER OF MSKCC PROPERTIES LLC, WHO HAS ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SR. VP OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IT IS THEN PRESENTED TO, AND REVIEWED BY, THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY OUTSIDE COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. PART VI, LINE 12C In 2021, MSK's conflict of interest (COI) program was implemented through three comprehensive policies for Memorial Sloan Kettering Cancer Center, Memorial Hospital for Cancer and Allied Diseases and Sloan-Kettering Institute for Cancer Research, which are outlined below: 1. Conflict of Interest and Commitment Policy (the "Individual COI Policy"). a. The Individual COI Policy applied to: (i) physicians and scientists with academic appointments at any level; (ii) any clinical provider who could independently write orders or prescriptions; (iii) individuals whose roles included the design, conduct or reporting of research and/or were engaged in human subject research; (iv) administrative employees with independent authority to make purchasing decisions or who were otherwise able to bind, negotiate on behalf, or execute agreements on behalf of, MSK; and (v) individuals that served on MSK institutional committees with responsibility for oversight of research, formulary, or purchasing decisions. b. MSK's Compliance COI Office ("Compliance") and the institutional conflict of interest committee (the "MSK COI Committee") were responsible for the administration of this policy, under the oversight of the newly-created committee of the Board (the "Board COI Committee") dedicated exclusively to discharging the Board's responsibility and authority over MSK's conflicts of interest program. c. Upon becoming covered by the Individual COI Policy, annually thereafter and/or as new significant interests arose, an individual was required to disclose financial interests and external relationships and activities ("interests"), whether paid or unpaid, that reasonably appeared to be related to the individual's institutional responsibilities. Covered Persons were required to disclose interests for themselves and immediate family members. d. Depending on the circumstances and based on established criteria, disclosed interests were reviewed by Compliance, the MSK COI Committee, MSK COI Committee designee(s), and/or the Board COI Committee to determine whether an individual conflict of interest existed or presented the perception thereof (i.e. whether an individual financial interest could directly and significantly impact an individual's institutional responsibilities, or an individual's interest could be directly and significantly impacted by their institutional responsibilities). e. The policy required any individual conflict of interest to be managed, reduced or eliminated. When a conflict of interest determination was made, the MSK COI Committee, the MSK COI Committee designee(s), or the Board COI Committee, as applicable, determined how to address it. For those conflicts deemed manageable, management strategies implemented included disclosure of the interest in relevant publications, presentations, consent forms, and educational materials; recusal and/or other limitation on role; independent oversight by a disinterested senior personnel member or committee; and temporary or permanent reduction, divestiture, relinquishment, or termination of an individual's interest. 2. Institutional Conflict of Interest Policy (the "Institutional COI Policy"). a. The Institutional COI Policy applied to financial interests and relationships ("interests") held by MSK as an institution, as well as those financial interests and relationships ("interests") held by five senior executive officers deemed "Institutional Officials,their immediate family members. Institutional Officials included the President and Chief Executive Officer, the Physician-In-Chief and Chief Medical Officer, the Chief Operating Officer, the Chief Financial Officer, and the Director of the Sloan-Kettering Institute for Cancer Research. b. Institutional interests held by MSK were made available to Compliance through regular reports from and ongoing engagement with relevant MSK departments. Institutional interests held by Institutional Officials were disclosed through the process described above in the Individual COI Policy, as well as the process described below in the Board COI Policy. c. The MSK COI Committee or MSK COI Committee designee(s) were responsible for determining whether an institutional conflict of interest existed; i.e. whether the institutional interest held by MSK or an Institutional Official (or their immediate family members) could, or could reasonably be perceived to, directly and significantly affect the design, conduct, reporting, review, or oversight of MSK research or the outcome of an MSK activity or decision. d. The policy required any institutional conflict of interest to be managed, reduced or eliminated. When an institutional conflict of interest determination was made, the MSK COI Committee and/or the MSK COI Committee designee(s) determined how to address it. For those conflicts deemed manageable, management strategies implemented included recusal of the applicable Institutional Official from decision-making regarding the arrangement and disclosure to relevant personnel; disclosure of the interest in relevant publications, presentations, consent forms, and educational materials; independent oversight by a disinterested senior personnel member or committee; and temporary or permanent reduction, divestiture, relinquishment, or termination of MSK's or an Institutional Official's institutional interest. 3. Boards of Governing Trustees Conflict of Interest Policy (the "Board COI Policy"). a. The Board COI Policy applied to Board members, officers, and other MSK senior leadership. Individuals covered by the Board COI Policy were required to disclose financial interests and relationships, as defined by the policy, annually and on an ongoing basis. Other entities in the same tax-exempt group had overlapping officers and Board members as described in Schedule O; such persons reported financial interests through this or related processes. b. The Board COI Committee was responsible for determining whether any interest disclosed under the Board COI Policy gave rise to a conflict of interest. The policy required that the members of the Board COI Committee vote, without the individual with the potential conflict present, to determine whether a conflict of interest existed. All members participating in the vote were required to be disinterested with respect to the transaction, arrangement, or relationship. c. The covered individual with the conflict of interest could make a presentation to the Board COI Committee, but could not participate in or influence the discussion of, or vote on, the proposed transaction, arrangement, or relationship. The existence and resolution of any conflict of interest, along with associated determinations made and votes taken, were required to be documented in writing. d. For any transaction, arrangement, or relationship that involved a conflict of interest, a conflict management plan could be implemented if doing so was in the best interests of MSK. Management plans could require disclosure, recusal or other limitation of role, independent oversight and confidentiality. PART VI, LINE 15 MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF TRUSTEES AND GOVERNING TRUSTEES HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS MARCH 2021, WHICH SET THE COMPENSATION FOR THE PERIOD APRIL 2021 TO MARCH 2022. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS COMMITTEE MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. PART VI, LINE 19 OUR AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL OUR DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND FILED 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST AND COMMITMENT POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. PART VII, SECTION A THIS IRS FORM 990 IS FILED UNDER GROUP EXEMPTION NUMBER 3475, EIN 91-2154267. THE ATTACHED LIST REPRESENTS MEMBERS FROM THE GOVERNING BOARDS OF THE FOLLOWING AFFILIATED INSTITUTIONS THAT MAKE UP OUR EXEMPT GROUP: MEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) EIN 13-1924236, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (MEM) EIN 13-1624082, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (SKI) EIN 13-1624182, S.K.I. REALTY, INC. (SKR) EIN 13-3389586, LOUIS V. GERSTNER JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (SKG) EIN 20-2212588, MSK INSURANCE US, INC. (MVI) EIN 83-0363317, AND MSKCC PROTON INC.,(MPI) EIN 35-2397819. ALSO INCLUDED IN THE GROUP IS MSK PROPERTIES LLC. EIN 35-2464610 WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER. MEMORIAL SLOAN KETTERING BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS, VICE CHAIR OF THE BOARD JAMIE C. NICHOLLS, VICE CHAIR OF THE BOARD. JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY ALAN D SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART, CHAIR OF THE BOARD CRAIG B. THOMPSON, M.D., BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III, HONORARY CHAIR OF THE BOARD PETER A. WEINBERG 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS MEMORIAL HOSPITAL BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE, HONORARY CHAIRMAN OF THE BOARD IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS, CHAIR OF THE BOARD JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY ALAN D SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III PETER A. WEINBERG 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS SLOAN KETTERING INSTITUTE BOARD OF GOVERNING TRUSTEES: RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON HENRY A. FERNANDEZ WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR., HONORARY CHAIRMAN OF THE BOARD JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. WILLIAM HELMAN MARGARET KEANE MARIE-JOSEE KRAVIS, CHAIR OF THE BOARD JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY ALAN D SCHNITZER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III PETER A. WEINBERG 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS S.K.I. REALTY BOARD OF DIRECTORS: RICHARD I. BEATTIE LOUIS V. GERSTNER, JR. JAMES G. NIVEN, PRESIDENT CLIFTON S. ROBBINS SCOTT M. STUART, CHAIRMAN OF THE BOARD DOUGLAS A. WARNER III 6 TOTAL BOARD MEMBERS 6 INDEPENDENT BOARD MEMBERS GERSTNER GRADUATE SCHOOL BOARD OF TRUSTEES: RICHARD I. BEATTIE ELLEN V. FUTTER LOUIS V. GERSTNER, JR., CHAIRMAN OF THE BOARD UNTIL DECEMBER 2021 MARIE-JOSEE KRAVIS ALAN D SCHNITZER SCOTT M. STUART CRAIG B. THOMPSON, M.D. BOARD MEMBER, PRESIDENT, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III 8 TOTAL BOARD MEMBERS 7 INDEPENDENT BOARD MEMBERS MSK INSURANCE U.S. BOARD OF DIRECTORS: DEBRA BERNS-EMPLOYEE NOT AN INDEPENDENT BOARD MEMBER KATHRYN MARTIN, DIRECTOR AND SECRETARY, EMPLOYEE NOT AN INDEPENDENT BOARD MEMBER STEPHEN C. SHERRILL, CHAIRMAN OF THE BOARD MARK SVENNINGSON, BOARD MEMBER AND PRESIDENT EMPLOYEE, NOT INDEPENDENT BOARD MEMBER JEFFREY P. JOHNSON, BOARD MEMBER AND VICE PRESIDENT MICHAEL P HARRINGTON, EMPLOYEE, NOT AN INDEPENDENT BOARD MEMBER 6 TOTAL BOARD MEMBERS 2 INDEPENDENT BOARD MEMBERS MSKCC PROTON INC., BOARD OF DIRECTORS: SIMON POWELL MD., EMPLOYEE NOT AN INDEPENDENT DIRECTOR 1 TOTAL DIRECTOR, 0 INDEPENDENT DIRECTORS PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS PAID TO SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. PART XI RECONCILIATION OF NET ASSETS, OTHER NON-OPERATING (EXPENSE): CHANGE IN POSTRETIREMENT $ 231,708,000 OTHER NON-OPER EXPENSE (12,201,000) TOTAL $ 219,507,000 PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 13123000 6974000 MSKCC MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501(C)3 10 MSKCC true MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 2792172 0 false 0 true 1.00000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY MEM RELATED 10452710 0 false 0 true 1.00000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 43910792 0 false 0 true 1.00000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 4761790 0 false 0 1.00000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 5076373 0 false 0 true 1.00000 MSK RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 96548292 0 false 0 true 1.00000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 9916032 0 false 0 true 1.00000 MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 25897360 0 false 0 true 1.00000 MEM PATHOLOGY GRP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 54980013 0 false 0 true 1.00000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 63040942 0 false 0 true 1.00000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 9618517 0 false 0 true 1.00000 MEM NEUROLOGY GRP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 14368486 0 false 0 true 1.00000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 6605121 0 false 0 true 1.00000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 172773407 0 false 0 true 1.00000 MSK HAUPPAUGE 1275 YORK AVENUE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 5832290 0 false 0 true 1.00000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 2068058 0 false 0 true 1.00000 MSK-REGIONAL NETWK 1275 YORK AVENUE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 17220511 0 false 0 true 1.00000 MSK BASKING RIDGE 1275 YORK AVENUE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 15429072 0 false 0 true 1.00000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 6827987 0 false 0 true 1.00000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 955233 0 false 0 true 1.00000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 5833381 0 false 0 true 1.00000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 12414279 0 false 0 true 1.00000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 2149982 0 false 0 true 1.00000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 8453616 0 false 0 true 1.00000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 4104412 0 false 0 true 1.00000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 9506650 0 false 0 true 1.00000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 20639669 0 false 0 true 1.00000 MSK HARRISON 1275 YORK AVENUE NY NY 10065 300831483 HEALTH CARE NY MEM RELATED 22077888 0 false 0 true 1.00000 MSK BERGEN 1275 YORK AVENUE NY NY 10065 611791803 HEALTH CARE NY MEM RELATED 13253556 0 false 0 true 1.00000 MSK MONMOUTH 1275 YORK AVE NY NY 10065 300937486 HEALTH CARE NY MEM RELATED 19879355 0 false 0 true 1.00000 PANAKEIA ENERGY 10000 MEMORIAL DR HOUSTON TX 77024 800891961 INVESTMENT DE MSK excluded under 512 -20298 320393 false -3650 false 0.99221 BTS LIQUIDATING LLC 1430 BROADWAY NY NY 10018 262602952 INVESTMENT NY MSK excluded under 512 -48112 205199 false 0 true 0.70000 MSK NASSAU 1275 YORK AVENUE NY NY 10065 611904151 health care NY MEM RELATED 13144981 0 false 0 true 1.00000 RALPH LAUREN CENTER 1275 YORK AVENUE NY NY 10065 320577172 health care NY MEM RELATED 594233 0 false 0 true 1.00000 CHARITABLE REMAINDER TRUSTS 142 N/A TWO SIGMA US ALL CAP EQUITY BATA CAYMEN 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY1-9007 INVESTMENT CJ MSK C -7243017 56167573 1.00000 true AXAR OFFSHORE FUND LTD PO BOX 309 UGLAND HOUSE GRAND CAYMAN CJ CJ KY1-1104 INVESTMENT CJ MSK c 31655582 197230327 0.79320 true false false false false false false false false false false false false false false true false false MEMORIAL MEDICAL CARE PC Q 89000 Cost